Task: Answer the multiple choice question.
Question: Which drug exhibits a -13.647% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a O=C(NCc1ccccc1)c1ccc(OCC2CCCO2)cc1
b O=[N+]([O-])c1ccc(N/N=C/c2ccc[nH]2)cc1
c CC(=O)c1cccc(NC(=O)CSc2ccc(-c3ccccn3)nn2)c1
d CC1(N2CCCCC2)CC2(O)C(=[N+]1[O-])CCC/C2=N\O
Answer: c. CC(=O)c1cccc(NC(=O)CSc2ccc(-c3ccccn3)nn2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)c1cccc(NC(=O)CSc2ccc(-c3ccccn3)nn2)c1
CC(=O)c1cccc(NC(=O)CSc2ccc(-c3ccccn3)nn2)c1
N-(3-acetylphenyl)-2-(6-pyridin-2-ylpyridazin-3-yl)sulfanylacetamide